Kakibibi Peace, Marangu-Boore Diana, Murila Florence
Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya
Division of Paediatric Pulmonology, Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
BMJ Open. 2025 Jan 11;15(1):e085026. doi: 10.1136/bmjopen-2024-085026.
Respiratory Distress Syndrome (RDS) is the most common complication of preterm neonates. It remains one of the major public health concerns that contribute to neonatal mortality and morbidity, especially in Africa, where 80% of neonatal mortality is estimated to be caused by preterm complications. Nasal Continuous Positive Airway Pressure (NCPAP) ventilation is the preferred mode of RDS treatment. However, NCPAP is not easily accessible to every preterm neonate in low- and middle-income countries, and this is the case in Kenya.
To determine the proportion of preterm neonates admitted to the newborn unit (NBU) at Kenyatta National Hospital (KNH), a tertiary referral hospital in Kenya, with a missed opportunity for NCPAP and to determine the barriers and facilitators of NCPAP utilisation.
We conducted a hospital-based cross-sectional study that employed interactive explanatory concurrent mixed methods. The quantitative approach determined the proportion of missed opportunities for NCPAP in preterm neonates admitted to the KNH newborn unit, while the qualitative approach explored the barriers and facilitators of NCPAP utilisation.
Preterm neonates of gestation less than 37 weeks in the first 48 hours of life who met the criteria for NCPAP. The key informants were mainly different staff cadres from the newborn unit, a procurement officer and a biomedical engineer.
The proportion of preterm infants admitted to the newborn unit with a missed opportunity for NCPAP, and the barriers and facilitators of NCPAP utilisation.
167 preterm neonates were reviewed from July to November 2021 and analysed of whom 33.5% (95% CI 26.8% to 41.0%) missed the opportunity to receive NCPAP. 20 key informants were interviewed from September to October 2021. Facilitators of NCPAP use reported were (1) training of health workers, (2) availability of NCPAP machines, (3) KNH being a national and tertiary referral hospital able to receive neonates referred with RDS, (4) global evidence that NCPAP use is beneficial and (5) technology development. Barriers to NCPAP use were mainly (1) inadequate number of NCPAP machines, (2) inadequate training and mentorship, (3) inadequate and inappropriate size of NCPAP consumables, (4) staff shortage, (5) long servicing turnaround time, (6) long cleaning turnaround time, (7) infrastructure challenges and (8) insufficient utilities.
The missed opportunity for NCPAP in preterm neonates in Kenya is high. Barriers to NCPAP are related to medical products and technologies, health workforce-related challenges and service delivery. We recommend the provision of more NCPAP machines including supporting infrastructure and appropriate consumables, human resource support, frequent training and mentorship on NCPAP use.
呼吸窘迫综合征(RDS)是早产儿最常见的并发症。它仍然是导致新生儿死亡和发病的主要公共卫生问题之一,尤其是在非洲,估计80%的新生儿死亡是由早产并发症引起的。经鼻持续气道正压通气(NCPAP)是RDS治疗的首选模式。然而,在低收入和中等收入国家,并非每个早产儿都能轻易获得NCPAP,肯尼亚就是这种情况。
确定肯尼亚一家三级转诊医院——肯雅塔国家医院(KNH)新生儿科收治的早产儿中错失接受NCPAP治疗机会的比例,并确定NCPAP使用的障碍和促进因素。
我们开展了一项基于医院的横断面研究,采用交互式解释性并行混合方法。定量方法确定了KNH新生儿科收治的早产儿中错失NCPAP治疗机会的比例,而定性方法则探讨了NCPAP使用的障碍和促进因素。
出生后48小时内孕周小于37周且符合NCPAP标准的早产儿。关键信息提供者主要是新生儿科不同级别的工作人员、一名采购官员和一名生物医学工程师。
新生儿科收治的早产儿中错失NCPAP治疗机会的比例,以及NCPAP使用的障碍和促进因素。
对2021年7月至11月期间的167名早产儿进行了回顾和分析,其中33.5%(95%CI 26.8%至41.0%)错失了接受NCPAP治疗的机会。2021年9月至10月对20名关键信息提供者进行了访谈。报告的NCPAP使用促进因素包括:(1)卫生工作者培训;(2)NCPAP机器的可用性;(3)KNH作为一家能够接收患有RDS转诊新生儿的国家级三级转诊医院;(4)NCPAP使用有益的全球证据;(5)技术发展。NCPAP使用的障碍主要有:(1)NCPAP机器数量不足;(2)培训和指导不足;(3)NCPAP耗材尺寸不合适且数量不足;(4)人员短缺;(5)维修周转时间长;(6)清洁周转时间长;(7)基础设施挑战;(8)公用设施不足。
肯尼亚早产儿错失NCPAP治疗机会的比例很高。NCPAP的障碍与医疗产品和技术、卫生人力相关挑战以及服务提供有关。我们建议提供更多NCPAP机器,包括支持性基础设施和合适的耗材、人力资源支持、关于NCPAP使用的频繁培训和指导。